SureTrader
Home > Boards > US OTC > Biotechs >

PharmaCyte Biotech Inc. (PMCB)

PMCB RSS Feed
Add PMCB Price Alert      Hide Sticky   Hide Intro
Moderator: mick, Hunchbackgeek, $Pistol Pete$, thenewmixer, fraum, concordia
Search This Board: 
Last Post: 1/18/2018 11:53:57 PM - Followers: 791 - Board type: Free - Posts Today: 0

  Welcome to PharmaCyte BioTech
An OTCQB Company

01-10-2018   /////\\\\\   https://www.americanbulls.com/SignalPage.aspx?lang=en&Ticker=PMCB

$PMCB/ 10 yr. black/daily/200ma 300ma 400ma 500ma 600ma PPS VOLUME 
 


PharmaCyte is a clinical stage biotechnology company developing therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as "Cell-in-a-Box." This technology will be used as a platform upon which therapies for several types of cancer and diabetes are being developed. For cancer, the therapy involves encapsulating genetically engineered human cells that convert the prodrug ifosfamide from its inactive form to its "cancer" killing form. These encapsulated live cells are implanted in a patient as close to the tumor as possible. Then ifosfamide is given IV at one-third the normal dose. When the ifosfamide comes in contact with the encapsulated live cells, they act as an artificial liver (where ifosfamide is normally activated) and activate the ifosfamide at the source of the cancer. For diabetes, PharmaCyte is developing a treatment for Type 1 diabetes and insulin-dependent Type 2 diabetes. PharmaCyte plans to encapsulate a human cell line that has been genetically engineered to produce, store and release insulin in response to the levels of blood sugar in the human body. The encapsulation will be done using the Cell-in-a-Box technology. Once the encapsulated cells are implanted in a diabetic patient they will function as a "bio-artificial pancreas" for purposes of insulin production.
 





FDA Grants Orphan Drug Designation to Pharmacyte Biotech for Pancreatic Cancer Treatment



European Medicines Agency (EMA), the European Commission has granted the Orphan Drug designation to PharmaCyte’s subsidiary,
PharmaCyte Biotech Europe Limited, for PharmaCyte’s pancreatic cancer treatment

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/orphans/2009/11/human_orphan_000395.jsp&mid=WC0b01ac058001d12b

 Company Address
   
PharmaCyte Biotech, Inc.

23046 Avenida de la Carlota, Suite 600
Laguna Hills, California 92652
Office Number: 917.595.2850
Facsimile Number: 917.595.2851
Email: info@PharmaCyte.com
http://pharmacyte.com/
 

Market Value:
$122,386,272 a/o Dec 19, 2016

Shares Outstanding:
848,904,665 a/o Aug 29, 2016

Authorized Shares:
1,490,000,000 a/o Aug 26, 2014

Float:
817,204,665 a/o Aug 29, 2016


For more updated information please visit: 


http://www.otcmarkets.com/stock/PMCB/profile


Transfer Agent:
Signature  Stock Transfer Inc. Plano TX  Ph # 972-612-4120

Investor Relations


Stonegate Capital Inc.
8201 Preston Road
Suite 325
Dallas, TX 75225
United States

 

   All News Releases: 

http://www.pharmacytebiotech.com/news/

 


What is Cell-in-a-Box®?

The Cell-in-a-Box® technology, developed by Austrianova, is a means to protect, isolate, storeand transport living cells. The proprietary technology can be used for a variety of purposes.
In healthcare, it facilitates the safe implantation of cells, holding them isolated from the immune system and allowing long term production of therapeutic molecules in patients. 
In biotechnology, the Cell-in-a-Box® technology protects cells in bioreactors and fermenters, while at the same time simplifying purification of bioproducts produced from the cells and reducing production cost. 
The technology can also be applied to probiotics, cosmetics and agriculture, environmental protection and monitoring, as well as forming the basis of a powerful research tool. 
The company’s proprietary cell packaging material, Gel8, used for the Cell-in-a-Box® technology, is derived from a naturally occurring material and is thus harmless to the environment, biologically inert and has been shown to be safe in humans.


http://austrianova.com/products/ 



Management Team:

Kenneth L. Waggoner, Chief Executive Officer and President
 

Gerald W. Crabtree, Ph.D. – Chief Operating Officer and Director


Carlos A. Trujillo – Chief Financial Officer and Director


Walter H. Gunzburg – Chief Scientific Officer


Dr. Matthias Lohr as Chairman of Scientific Advisory Board


Thomas Liquard - Chairman of the Audit Committe

  Dr. Eva Maria (Lilli) Brandtner – Director of Diabetes Program Development

Dr. Manuel Hidalgo, Scientific Advisory Board

 


 

 

 


***DISCLAIMER***
-  The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
-  We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
-  There are no guarantees when buying or selling any security.





 
 


                                   

 
 
SureTrader
PMCB
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PMCB News: Quarterly Report (10-q) 12/14/2017 04:51:05 PM
PMCB News: Current Report Filing (8-k) 10/10/2017 08:31:01 AM
PMCB News: Notice of Effectiveness (effect) 09/29/2017 06:01:57 AM
PMCB News: Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) 09/28/2017 04:18:18 PM
PMCB News: Securities Registration Statement (simplified Form) (s-3) 09/13/2017 09:26:54 AM
PostSubject
#79557  Sticky Note HUGE READ MY FRIEND/ PHARMACYTE BIOTECH/ $PMCB/ STAY mick 01/10/18 10:06:32 AM
#79551  Sticky Note $PMCB PharmaCyte Announces Completion of Master Cell Ban $Pistol Pete$ 01/10/18 09:52:04 AM
#79107  Sticky Note $PMCB PharmaCyte Biotech Meets with Oncology Advisory Bo $Pistol Pete$ 12/12/17 02:13:03 AM
#78845  Sticky Note Daily SCAM ALERT. Below are the headlines of concordia 11/30/17 11:31:41 AM
#80119   You’re right, and 1234 is wrong... PINKribbon 01/18/18 11:53:57 PM
#80118   So why did Dr. Tong join pmcb board? efood125 01/18/18 10:53:47 PM
#80117   Wrong !!! rcstock 01/18/18 10:00:52 PM
#80116   I agree with you 1234jklm 01/18/18 09:17:34 PM
#80115   Good to hear from you, GO PMCB Sainghip 01/18/18 08:47:55 PM
#80114   Good to hear from you. Go PMCB Sainghip 01/18/18 08:37:20 PM
#80113   We never had an ascites trial...and the mouse efood125 01/18/18 08:22:23 PM
#80112   I am happy for you...when china buys this efood125 01/18/18 08:19:16 PM
#80111   I made 20% gains on my investments last Fordman65 01/18/18 07:45:30 PM
#80110   I guess that depends on the success of BioInvestor4 01/18/18 07:36:43 PM
#80109   Bio what is your opinion of what the A2Z 01/18/18 07:08:24 PM
#80108   Buy at 3 sell at 7. 1234jklm 01/18/18 06:59:48 PM
#80107   But our ascites trial failed 1234jklm 01/18/18 06:55:05 PM
#80106   https://industrytoday.co.uk/health_and_safety/worldwide-ascites-market-is-estima JODI1 01/18/18 06:50:29 PM
#80105   $PMCB One Month Chart http://www.stockscores. $Pistol Pete$ 01/18/18 04:42:22 PM
#80104   $$PMCB one month Gains is Impressive. Hunchbackgeek 01/18/18 04:32:16 PM
#80103   Yep $Pistol Pete$ 01/18/18 04:02:03 PM
#80102   Not too bad for the close today $Pistol Pete$ 01/18/18 04:01:56 PM
#80101   Looks like a good time to load. Hunchbackgeek 01/18/18 02:41:19 PM
#80100   Still holding 7s Massman33 01/18/18 02:38:18 PM
#80099   $PMCB waiting for PH my Friend $Pistol Pete$ 01/18/18 01:16:09 PM
#80098   We had a 4 green close. It's pullback. Massman33 01/18/18 01:14:29 PM
#80097   Not really $Pistol Pete$ 01/18/18 12:02:19 PM
#80096   Ok the shakeout took place and it was longboarder7892 01/18/18 11:28:28 AM
#80095   I don't see any sell orders stacking up. Syzygenic 01/18/18 11:21:10 AM
#80094   buying pressure has eased off so now the tulla236a 01/18/18 11:03:07 AM
#80093   Profit taking. A close friend of mine had rcstock 01/18/18 10:57:40 AM
#80092   If there's no actual news before then, you're XCypher73 01/18/18 10:45:01 AM
#80091   It's going back to .03 soon...that's how pmcb works. WallSt1 01/18/18 10:39:09 AM
#80090   Don't y'all always put your sell trades in Pmcbinv 01/18/18 10:39:02 AM
#80089   In the fundamental world yes, in pmcb world- Brian903 01/18/18 10:31:46 AM
#80088   I can't speak to a possible ruse, but Syzygenic 01/18/18 10:30:21 AM
#80085   Is this morning a ruse? Nope, this is Brian903 01/18/18 10:26:23 AM
#80082   I hope you are right my friend! BioInvestor4 01/18/18 10:05:34 AM
#80081   Its hard to predict what the pps number oldmusky 01/18/18 09:55:43 AM
#80080   I believe the MACD is suggesting a massive Syzygenic 01/18/18 09:52:29 AM
#80079   Bio, you are way out my friend... 15 JODI1 01/18/18 09:43:45 AM
#80078   8s coming Massman33 01/18/18 09:43:09 AM
#80077   I see this running to at least 15 BioInvestor4 01/18/18 09:09:15 AM
#80076   How about a little .08s today? efood125 01/18/18 09:05:34 AM
#80075   If you are long and always had the JODI1 01/18/18 08:43:26 AM
#80074   Im the same 2014 might be 13 i'll The Promised Land 01/18/18 07:13:52 AM
#80073   With almost a 1B shares outstanding by now Runuvi 01/18/18 06:15:44 AM
#80072   The annual reports don’t show this. 1234jklm 01/18/18 05:29:29 AM
#80071   It’s not the traders that at are keeping Runuvi 01/18/18 04:43:13 AM
#80070   I just wish traders would let it get 1234jklm 01/18/18 03:53:09 AM
#80069   I do not blame anyone trading, thats what Brian903 01/17/18 10:23:35 PM
#80068   Means nothing to me....been there, done that, a-lot Brian903 01/17/18 10:19:23 PM
#80067   We are up 220% in the last 50 days 1234jklm 01/17/18 10:16:07 PM
#80066   Would be amazing as long as it is Brian903 01/17/18 10:14:13 PM
PostSubject